C1q as a target molecule to treat human disease: What do mouse studies teach us?
The complement system is a field of growing interest for pharmacological intervention. Complement protein C1q, the pattern recognition molecule at the start of the classical pathway of the complement cascade, is a versatile molecule with additional non-canonical actions affecting numerous cellular p...
Main Authors: | Kristina Schulz, Marten Trendelenburg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.958273/full |
Similar Items
-
Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery
by: Kristina Schulz, et al.
Published: (2023-12-01) -
Autoantibodies against complement component C1q in systemic lupus erythematosus
by: Marten Trendelenburg
Published: (2021-01-01) -
Complement C1q Enhances Primary Hemostasis
by: Claudia Donat, et al.
Published: (2020-07-01) -
Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages
by: Claudia Donat, et al.
Published: (2019-11-01) -
The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor
by: Anneza Panagiotou, et al.
Published: (2018-05-01)